Resverlogix (TSX:RVX) Price-to-Operating-Cash-Flow : (As of May. 22, 2024)

View and export this data going back to 2005. Start your Free Trial

What is Resverlogix Price-to-Operating-Cash-Flow?

As of today (2024-05-22), Resverlogix's share price is C$0.06. Resverlogix's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.01. Hence, Resverlogix's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Resverlogix's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, Resverlogix's highest Price-to-Operating-Cash-Flow Ratio was 25.29. The lowest was 0.00. And the median was 0.00.

TSX:RVX's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.84
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Resverlogix's Cash Flow from Operations per share for the three months ended in Dec. 2023 was C$-0.02. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.01.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 50.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 49.70% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 24.50% per year.

During the past 13 years, Resverlogix's highest 3-Year average Operating Cash Flow per Share Growth Rate was 62.00% per year. The lowest was -84.80% per year. And the median was 3.90% per year.

Resverlogix Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Resverlogix's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Resverlogix Price-to-Operating-Cash-Flow Chart

Resverlogix Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Resverlogix Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	35.00	-

Competitive Comparison of Resverlogix's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Resverlogix's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Resverlogix's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Resverlogix's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Resverlogix's Price-to-Operating-Cash-Flow falls into.

Resverlogix Price-to-Operating-Cash-Flow Calculation

Resverlogix's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.06	/	-0.014
	=

Resverlogix's Share Price of today is C$0.06.
Resverlogix's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.01.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Resverlogix Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Resverlogix's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Resverlogix (TSX:RVX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Resverlogix Corp (TSX:RVX) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

RVXCF:USA RFS:Germany

Address

4820 Richard Road South West, Suite 300, Calgary, AB, CAN, T3E 6L1

Website

https://www.resverlogix.com

Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.

Executives

Aaron Bradley Cann

Senior Officer

Resverlogix (TSX:RVX) Headlines

No Headlines